Eli Lilly LLY
NYSE LLY
$1,271.10 -12.56 (-0.98%)
As of: Oct 21, 2026 · 3:59 PM EDT

Eli Lilly (LLY) Non-Current Debt (2009 - 2026)

Updated

Eli Lilly's Non-Current Debt was $47.86 billion in Q2 2026, up 40.0% from $34.18 billion a year earlier and up 21.6% from the prior quarter.

Analysis

Eli Lilly (LLY) Non-Current Debt (2009 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Debt at Eli Lilly came in at $40.87 billion, up 43.3% from FY2024.

  • Non-Current Debt has now increased for three consecutive years, with a five-year compound annual growth rate of 19.8% (FY2020 to FY2025).
  • In earlier years, Non-Current Debt was $28.53 billion in FY2024 (+55.7%), $18.32 billion in FY2023 (+24.3%), $14.74 billion in FY2022 (-4.0%) and $15.35 billion in FY2021 (-7.5%).
  • The Q2 2026 figure marks the highest quarterly Non-Current Debt in data going back to Q2 2009.
  • Compared with a year earlier, Non-Current Debt has increased for 14 straight quarters, with growth averaging 42.5% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Debt over five years was Q3 2024 (growth of 62.1%); the worst was Q3 2022 (a decline of 8.9%).
  • Per Business Quant data, LLY's Non-Current Debt in the three quarters before Q2 2026 was $39.37 billion (Q1 2026), $40.87 billion (Q4 2025) and $40.87 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 Vertex Pharmaceuticals 133.33 Bn 105.34 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.86 Bn
Mar 31, 2026 39.37 Bn
Dec 31, 2025 40.87 Bn
Sep 30, 2025 40.87 Bn
Jun 30, 2025 34.18 Bn
Mar 31, 2025 34.50 Bn
Dec 31, 2024 28.53 Bn
Sep 30, 2024 29.05 Bn
Jun 30, 2024 23.73 Bn
Mar 31, 2024 24.56 Bn
Dec 31, 2023 18.32 Bn
Sep 30, 2023 17.92 Bn
Jun 30, 2023 18.16 Bn
Mar 31, 2023 18.88 Bn
Dec 31, 2022 14.74 Bn
Sep 30, 2022 14.14 Bn
Jun 30, 2022 14.69 Bn
Mar 31, 2022 15.15 Bn
Dec 31, 2021 15.35 Bn
Sep 30, 2021 15.52 Bn
API Access

Eli Lilly Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=LLY&period=max&api_key=YOUR_API_KEY